Science policy affects a broad range of issues, ranging from data sharing and gene editing, to intellectual property and regulation.
Patient data is extremely valuable for biomedical and healthcare research.
Government investment plays an important part in supporting scientific excellence in the UK.
Research is an essential part of being ready for and responding to public health emergencies.
Good research practice is one of the foundations of high-quality research.
The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.
The European Union is revising regulations governing the manufacture and sale of medical devices.
Gene editing allows scientists to change gene sequences by adding, replacing or removing sections of DNA.
Sharing data from clinical trials benefits other researchers working on different studies and builds public trust by showing that clinical trials are valuable to healthcare.
The new European Data Protection Regulation was agreed in April 2016 and will take effect from May 2018.
Open access ensures that original research publications – including journal articles, book chapters and monographs – are available to everyone to read and re-use at no cost.
The European Commission is developing plans to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.
Almost every major breakthrough in human and veterinary medicine has depended on the use of animals in the research, development or testing of new therapies.
Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.
The Expert Advisory Group on Data Access provides strategic advice to its funders about the scientific, legal and ethical issues of data access for cohort studies and human genetics research.
The Public Health Research Data Forum brings together more than 20 funders of global health research to support ways of sharing health research data.
We propose concrete interventions to combat the real and growing threat of antimicrobial resistance.
We commissioned Ipsos MORI to undertake research into public attitudes towards commercial organisations accessing health, medical and genetic data.
A national survey, on behalf of a consortium of UK public research funders, into the factors that affect public engagement by researchers across the UK.
Briefings and responses
Higher Education Funding Council for England
House of Commons Science and Technology Committee
Royal Society/British Academy